-
Mashup Score: 26Decoding the Autoantibody ‘Reactome’ in Cancer Immunotherapy | The Mark Foundation for Cancer Research - 3 month(s) ago
This project explores the diverse effects of autoantibodies on cancer immunotherapy outcomes, seeking to understand why patients respond so differently to treatment. Using a new antibody profiling…
Source: themarkfoundation.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17Decoding the Autoantibody ‘Reactome’ in Cancer Immunotherapy | The Mark Foundation for Cancer Research - 3 month(s) ago
This project explores the diverse effects of autoantibodies on cancer immunotherapy outcomes, seeking to understand why patients respond so differently to treatment. Using a new antibody profiling…
Source: themarkfoundation.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Engineering Multimodal Immunotherapies against Small-Cell Neuroendocrine Tumors | The Mark Foundation for Cancer Research - 6 month(s) ago
Small-cell neuroendocrine tumors (SCNTs) represent an aggressive group of difficult-to-treat tumors with shared characteristics that pose significant challenges in patient care.
Source: themarkfoundation.orgCategories: Latest Headlines, Oncologists1Tweet
Congrats to Fred Hutch's @aaronmring on receiving @TheMarkFdn's 2024 Emerging Leader Award! The award will support Ring's work decoding the autoantibody ‘reactome’ in cancer #immunotherapy. Read more: https://t.co/GT7lPnvnWs